EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy

Yong Yu, Jingying Li, Kaiming Ren

Frontiers in Cell and Developmental Biology · 12.05.2023 · 11

DOI: 10.3389/fcell.2023.1196226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.05.2023. Verfasst von Yong Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is commonly accompanied by alterations in the expression of metabolic enzymes. These metabolic enzymes not only catalyze the intracellular metabolic reaction, but also participate in a series of molecular events to regulate tumor initiation and development. Thus, these enzymes may act as promising therapeutic targets for tumor management. Phosphoenolpyruvate carboxykinases (PCKs) are the key enzymes involved in gluconeogenesis, which mediates the conversion of oxaloacetate into phosphoenolpyruvate. Two isoforms of PCK, namely cytosolic PCK1 and mitochondrial PCK2, has been found. PCK not only participates in the metabolic adaptation, but also regulates immune response and signaling pathways for tumor progression. In this review, we discussed the regulatory mechanisms of PCKs expression including transcription and post-translational modification. We also summarized the function of PCKs in tumor progression in different cellular contexts and explores its role in developing promising therapeutic opportunities.

Schlagwörter

Stichwörter der Autor:innen

cancergluconeogenesisimmunitymetabolic reprogrammingphosphoenolpyruvate carboxykinase

Autor:innen und Institutionen

  • Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

Zitieren

APA

Yu, Y., Li, J., & Ren, K. (2023). Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1196226

Vancouver

Yu Y, Li J, Ren K. Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1196226

BibTeX
@article{Yu2023,
  author = {Yu, Yong and Li, Jingying and Ren, Kaiming},
  title = {Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1196226}
}
Kostenlos starten →